Mirae Asset Healthcare Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return Index
NAV: ₹49.41-1.04%
08 Jul 2026
Loading…
| Asset | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Equity | 99.36% | 99.96% | 99.92% | 99.72% | 99.75% | 99.46% |
| Debt | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Others (incl. cash) | 0.64% | 0.04% | 0.06% | 0.27% | 0.24% | 0.53% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 19,12,104 | 344.03 | 11.13% | -0.63%↓ |
| Divis Laboratories Ltd. | Healthcare | 3,72,182 | 248.13 | 8.03% | -0.20%↓ |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | 9,19,340 | 199.26 | 6.45% | 0.06%↑ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 8,69,397 | 197.78 | 6.40% | -0.72%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 2,28,296 | 186.67 | 6.04% | 0.11%↑ |
| Laurus Labs Ltd. | Healthcare | 9,87,748 | 134.53 | 4.35% | 0.65%↑ |
| Lupin Ltd. | Healthcare | 5,82,670 | 132.13 | 4.28% | -0.29%↓ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 10,12,180 | 131.94 | 4.27% | -0.17%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 8,92,330 | 127.28 | 4.12% | -0.10%↓ |
| Fortis Healthcare Ltd. | Healthcare | 12,93,084 | 120.06 | 3.88% | -0.18%↓ |
| Alkem Laboratories Ltd. | Healthcare | 2,00,895 | 110.45 | 3.57% | 0.07%↑ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 14,45,186 | 109.67 | 3.55% | 0.27%↑ |
| Onesource Specialty Pharma Ltd. | Healthcare | 5,51,345 | 100.6 | 3.26% | 0.04%↑ |
| Eris Lifesciences Ltd. | Healthcare | 7,17,262 | 100.35 | 3.25% | 0.29%↑ |
| Sai Life Sciences Ltd. | Healthcare | 8,59,329 | 99.68 | 3.23% | 0.10%↑ |
| Cipla Ltd. | Healthcare | 7,08,610 | 99.28 | 3.21% | 0.06%↑ |
| Aster DM Healthcare Ltd. | Healthcare | 13,14,393 | 95.73 | 3.10% | -0.13%↓ |
| Ipca Laboratories Ltd. | Healthcare | 6,12,350 | 93.35 | 3.02% | -0.01%↓ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 4,88,489 | 78.52 | 2.54% | 0.55%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 7,51,477 | 72.53 | 2.35% | -0.08%↓ |
| Sector | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Healthcare | 98.24% | 98.84% | 98.54% | 98.16% | 98.11% | 97.65% |
| Chemicals | 1.12% | 1.11% | 0.84% | 1.04% | 1.04% | 1.22% |
| Services | - | - | 0.54% | 0.52% | 0.60% | 0.59% |
26.5 / 100
Weighted average Value score is 26.5. This indicates that portfolio is relatively reasonably valued using composite of value measures.
81.0 / 100
Weighted average Price Momentum score is 81.0. This indicates that portfolio has high momentum using composite of momentum measures.
84.5 / 100
Weighted average Quality score is 84.5. This indicates that portfolio has high quality using composite of quality measures.
75.2 / 100
Weighted average QVM score is 75.2. This indicates that portfolio has high QVM score and hence could be considered for investment.